CATrends: Emails Offering Free Gifts
Lawsuits target misleading subject lines.
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
Lawsuits target misleading subject lines.
MADISON, CONN. Jan. 27, 2026 – Beverage giant Keurig Dr Pepper is deceptively marketing its single-serve K-Cup pods as “recyclable” in violation of state and federal laws, according to an…
TINA.org nails down the truth behind these US-origin claims.
TINA.org files complaints over company’s deceptive “recyclable” claims.
Steve Toloken, Plastics News